Bio Key International Stock Performance
BKYI Stock | USD 1.68 0.02 1.18% |
The firm shows a Beta (market volatility) of 0.95, which signifies possible diversification benefits within a given portfolio. BIO Key returns are very sensitive to returns on the market. As the market goes up or down, BIO Key is expected to follow. BIO Key International has an expected return of -0.0843%. Please make sure to confirm BIO Key International potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if BIO Key International performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days BIO Key International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, BIO Key is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 1:18 | Dividend Date 2020-11-20 | Last Split Date 2023-12-21 |
1 | BIO Key exotic insider transaction detected | 02/21/2024 |
2 | Humanity International Investments Hits Major Milestones in Digital Identity with the Humanity Protocol Initiative in Partnership with BIO-key International | 03/12/2024 |
3 | Analyzing MongoDB BIO-key International - Defense World | 03/21/2024 |
4 | Identity and Access ManagementCybersecurity Solutions Provider BIO-key International Hosts Q4 Investor Call Tues., Apr. 2nd at 10am ET | 03/27/2024 |
5 | Identity and Access Management Software Provider BIO-key Preliminary 2023 Results Operating Loss Trimmed Approx. 3.5M on Approx. 29 percent Revenue Growth to 9.... | 04/01/2024 |
6 | Earnings call BIO-key anticipates growth and profitability in 2024 | 04/03/2024 |
7 | Switzerlands Canton of Ticino Implements BIO-keys Multi-Factor Authentication Solution in its Information Systems Center | 04/09/2024 |
Begin Period Cash Flow | 2.8 M |
BIO |
BIO Key Relative Risk vs. Return Landscape
If you would invest 187.00 in BIO Key International on January 20, 2024 and sell it today you would lose (19.00) from holding BIO Key International or give up 10.16% of portfolio value over 90 days. BIO Key International is currently does not generate positive expected returns and assumes 4.191% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than BIO, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
BIO Key Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIO Key's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIO Key International, and traders can use it to determine the average amount a BIO Key's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0201
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BKYI |
Estimated Market Risk
4.19 actual daily | 37 63% of assets are more volatile |
Expected Return
-0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BIO Key is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIO Key by adding BIO Key to a well-diversified portfolio.
BIO Key Fundamentals Growth
BIO Stock prices reflect investors' perceptions of the future prospects and financial health of BIO Key, and BIO Key fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIO Stock performance.
Return On Equity | -1.26 | ||||
Return On Asset | -0.27 | ||||
Profit Margin | (1.06) % | ||||
Operating Margin | (0.42) % | ||||
Current Valuation | 3.71 M | ||||
Shares Outstanding | 1.81 M | ||||
Price To Earning | (2.55) X | ||||
Price To Book | 1.00 X | ||||
Price To Sales | 0.39 X | ||||
Revenue | 9.1 M | ||||
Gross Profit | 3.44 M | ||||
EBITDA | (6.8 M) | ||||
Net Income | (9.14 M) | ||||
Cash And Equivalents | 4.89 M | ||||
Cash Per Share | 0.58 X | ||||
Total Debt | 2.22 M | ||||
Debt To Equity | 0.05 % | ||||
Current Ratio | 3.50 X | ||||
Book Value Per Share | 6.28 X | ||||
Cash Flow From Operations | (4.16 M) | ||||
Earnings Per Share | (19.62) X | ||||
Market Capitalization | 3.04 M | ||||
Total Asset | 11.91 M | ||||
Retained Earnings | (114.81 M) | ||||
Working Capital | 4.73 M | ||||
Current Asset | 9.88 M | ||||
Current Liabilities | 1.72 M | ||||
About BIO Key Performance
To evaluate BIO Key International Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when BIO Key generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare BIO Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand BIO Key International market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents BIO's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 994.93 | 1,045 | |
Return On Tangible Assets | (0.96) | (1.00) | |
Return On Capital Employed | (1.53) | (1.46) | |
Return On Assets | (0.81) | (0.85) | |
Return On Equity | (1.75) | (1.66) |
Things to note about BIO Key International performance evaluation
Checking the ongoing alerts about BIO Key for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIO Key International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.BIO Key generated a negative expected return over the last 90 days | |
BIO Key may become a speculative penny stock | |
BIO Key has high historical volatility and very poor performance | |
BIO Key has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 9.1 M. Net Loss for the year was (9.14 M) with profit before overhead, payroll, taxes, and interest of 3.44 M. | |
BIO Key International currently holds about 4.89 M in cash with (4.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
BIO Key has a poor financial position based on the latest SEC disclosures | |
Latest headline from benzinga.com: Switzerlands Canton of Ticino Implements BIO-keys Multi-Factor Authentication Solution in its Information Systems Center |
- Analyzing BIO Key's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIO Key's stock is overvalued or undervalued compared to its peers.
- Examining BIO Key's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIO Key's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIO Key's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIO Key's stock. These opinions can provide insight into BIO Key's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is BIO Key's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.62) | Revenue Per Share 17.484 | Quarterly Revenue Growth 0.323 | Return On Assets (0.27) | Return On Equity (1.26) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.